Preclinical research utilizing mouse models has demonstrated the efficacy of nano-TQ in reducing inflammation, erythema, scaling, epidermal thickness, and cytokine levels such as TNF-α and IL-17 in psoriatic lesions. This evidence concerns the gene TNF and Erythema.